affiliated with the worldwide GeoSentinel network. Our goal was to provide evidence-based information on regional illness patterns that could be used to update travel medicine recommendations for future travelers to the region. In addition, surveillance data collected during the 2009 H1N1 influenza outbreak from these clinics provided an opportunity to study the impact of the outbreak on travel-associated illness patterns among visitors to Mexico and Central America.
METHODS
GeoSentinel sites are specialized travel or tropical medicine clinics on 6 continents; providers from these clinics collect sentinel surveillance data for all ill travelers who visit the clinic during or after travel. These data include a broad sample of travel destinations and of morbidity among persons who become ill while traveling or when they return from travel.
Detailed methods for patient recruitment, inclusion criteria, and limitations of the GeoSentinel database are described elsewhere [5] . In brief, patients must have crossed an international border within 10 years before the clinic visit and have sought medical advice for a presumed travel-related illness. Anonymous surveillance data (including travel history) that cannot be linked to an individual patient are entered into a database at a central data center. Final diagnoses are assigned codes by the treating clinician from a standardized list of possible individual diagnoses that are also categorized under 21 broad syndromes. All sites use the best available reference diagnostic test in their own country. Patients can be assigned as many diagnosis codes as needed. Because most infections are associated with fever, diagnoses predominantly localized to one organ system were included in that organ-system syndrome category and were not attributed to the broader category of systemic febrile disease.
The GeoSentinel data collection protocol underwent ethical review and was classified as nonresearch public health surveillance. As such, it was not subject to institutional review board requirements.
Data entered into the GeoSentinel database from all sites from 11 December 1996 through 23 February 2010 were examined. Data were extracted by identifying all travelers who were seen after travel to Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, and Panama. These travelers included tourists, students, business travelers, and persons visiting friends or relatives.
Statistical Analysis
Proportionate morbidity (PM) was expressed as the number of patients with a specific syndrome or diagnosis per 1000 ill travelers returned from Mexico or Central America. Statistical differences between groups were analyzed using the v 2 test for categorical variables and the Wilcoxon rank-sum test for continuous variables. All diagnoses were examined and ranked according to syndrome groups. The top 5 diagnoses in each of the top 5 syndromic groups were queried from the database. A subanalysis of the PM for the top 5 diagnoses compared age, sex, pretravel advice, reason for travel, trip duration, and hospitalization. The effect size of demographic and trip characteristics on selected diagnoses was estimated using bivariate odds ratios (ORs). A 2-sided P value # .05 was considered to be statistically significant. SAS software, version 9.2 (SAS Institute) was used for statistical calculations.
RESULTS

Demographic Characteristics of Travelers Returning From Mexico and Central America
From December 1996 through February 2010, 4779 ill returned travelers to Mexico and Central America were included. Females represented 54% of the ill returned travelers. The mean age (6 standard deviation [SD]) was 35.9 6 14.7 years, with a median trip duration of 17 days (interquartile range, 8-43 days). Most were tourists (68%), followed by missionaries/aid workers/ volunteers (14%), business travelers (10%), travelers visiting friends or relatives (5%), and students (3%). Two hundred twenty-five ill returned travelers (5%) were hospitalized as a result of a travel-related illness. Most (66%) of the travel originated from the United States and Canada, 27% were from Western Europe, and the remaining 12% traveled from the rest of the world. Forty-eight percent of ill returned travelers had sought pretravel advice from a health provider (Table 1) . Individuals traveling .7 days were more likely to have received pretravel advice than were short-term travelers (50% vs. 29%; OR, 2.4; 95% CI, 2.1-2.8; P , .0001).
Morbidity Patterns Among Travelers Returning From Mexico and Central America
Overall, the most common syndrome groupings among ill travelers returning from Mexico or Central America were acute diarrhea, dermatologic, and systemic febrile illnesses, followed by chronic diarrhea, other gastrointestinal, respiratory, nonspecific symptoms, and injuries and musculoskeletal illnesses ( Table 2 ). Dermatologic illness accounted for the highest PM among ill returned travelers to Guatemala, Belize, Costa Rica, and Panama (Table 3) . Moreover, the PM for dermatologic illness was nearly 2-fold higher than the PM for acute diarrheal diseases among travelers to Costa Rica and Panama. Ill returned travelers residing in the United States had significantly higher PM for acute diarrhea after visits to Mexico and Central America, compared with ill returned travelers from Canada and Western Europe (P , .0001). Western Europeans returning from Mexico and Central America had a higher PM for chronic diarrhea, compared with their North American counterparts (P , .0001). Three hundred five travelers with postinfectious irritable bowel syndrome (PI-IBS), defined as diarrheal illness during travel, followed by posttravel chronic abdominal pain (usually cramping and of variable intensity) and altered bowel habits in the absence of any organic cause of at least 12 weeks duration, and 24 additional travelers with postinfectious lactose intolerance were identified after they had returned home. The vast majority of patients with PI-IBS were travelers from the United States and Canada (90.3%), with the same proportion of men and women affected (P 5 .9). Ill returned travelers visiting friends or relatives (P 5 .03) and students (P 5 .004) had the lowest PM for PI-IBS, whereas missionaries (P , .0001) had the highest PM, compared with tourists. Finally, older travelers had less diarrhea, compared with their younger counterparts (P 5 .0002). The PM for acute diarrheal illness was similar among ill returning travelers who received pretravel advice, compared with those who did not receive pretravel advice from a travel medicine provider (P 5 .1).
Unspecified viral syndrome and dengue were the 2 most common diagnoses among returned travelers with a systemic febrile illness (Table 3) . Fifty-seven cases of cutaneous myiasis were diagnosed, most of them among travelers who had returned from Belize (n 5 21; PM, 130.4 cases per 1000 patients) and Costa Rica (n 5 22; PM, 35.4 cases per 1000 patients), followed by Guatemala (n 5 6, PM, 15.2 cases per 1000 patients), El Salvador (n 5 1; PM, 10.1 cases per 1000 patients), Nicaragua (n 5 1; PM, 5.4 cases per 1000 patients), and Mexico (n 5 6; PM, 3.5 cases per 1000 patients). In addition, 61 cases of cutaneous leishmaniasis were diagnosed: 41 from Costa Rica (PM, 65.9 cases per 1000 patients), 7 from Belize (PM, 43.5 cases per 1000 patients), 4 from Panama (PM, 29.2 cases per 1000 patients), 6 from Guatemala (PM, 15.2 cases per 1000 patients), and 3 from Mexico (PM, 1.7 cases per 1000 patients).
Uncommon diagnoses seen among nonimmigrant travelers included acute Chagas disease, fascioliasis, onchocerciasis, neurocysticercosis, brucellosis, Bordetella pertussis infection, leptospirosis, acute HIV infection, acute hepatitis A, and rubella (Table 4) .
Malaria Among Travelers Returning From Mexico and Central America
Fifty-four cases of malaria among ill returned travelers who had visited Mexico or Central America were identified over the past 10 years. Eighteen cases were identified in travelers returning from Honduras, 14 from Guatemala, 4 from Costa Rica, 4 from Mexico, 1 from Panama, and 1 from Belize. No cases were identified among ill travelers returned from El Salvador or Nicaragua. Only 19 identified cases (36%) were in female individuals, and the mean age 6 SD was 36.7 6 12.3 years. Most of the ill returned travelers with malaria were tourists (56.5%), followed by missionaries (18.9%), travelers visiting friends and relatives (11.3%), students (9.4%), and business travelers (3.8%). Most of the identified malaria cases were due to P. vivax (40), followed by Plasmodium falciparum [5] , Plasmodium ovale [2] , and Plasmodium malariae [1] . Plasmodium species was not determined for 6 cases. The highest PM for malaria among ill returned travelers visiting the studied countries was in Honduras (79.6 cases per 1000 patients), followed by Guatemala (34.4 cases per 1000 patients), Panama (7.0 cases per 1000 patients), Costa Rica (6.1 cases per 1000 patients), Belize (5.8 cases per 1000 patients), and Mexico (2.2 cases per 1000 patients). influenza outbreak was identified, but the proportion of those who obtained pretravel health advice decreased (P , .0001). The proportion of hospitalizations also increased among ill travelers returning from Mexico after H1N1 influenza (P , .0001). The pattern of respiratory illnesses diagnosed in ill travelers returned from Mexico and Central America is shown in Figure 1 Among ill returned travelers who had a respiratory presenting symptom, unspecified upper respiratory tract infections remained the most common diagnosis before (PM, 18.6 cases per 1000 patients) and after (PM, 59.8 cases per 1000 patients; P , .0001) 31 March 2009, when the H1N1 influenza outbreak was identified. From April 2009 through February 2010, the PM for influenza, influenza-like illness (P , .0001), and acute bronchitis (P , .02) also increased. Fifty ill returned travelers who visited Mexico and Central America developed influenza, including infection due to H1N1 strains, and influenza-like illness.
DISCUSSION
Using a sample of 4779 ill returned travelers, we elucidated illness patterns for Mexico and Central America that can direct pretravel advice and diagnosis of illness in future travelers to the region. Consistent with prior reports from this and other developing regions, diarrhea is the most common reason for seeking posttravel medical care [5] . As shown by Alon et al [6] , we observed that elderly ill returned travelers had a lower PM for diarrhea, compared with younger travelers. This observed lower proportion of diarrhea among older travelers could possibly be attributed to increased dietary caution in this age group, the development of immunity from earlier travel, or the possibility that the older travelers have comparatively greater numbers of visits for other health problems. As noted elsewhere [7] , visiting a travel medicine practitioner for medical advice before visiting Mexico and Central America was not associated with a lower proportion of acute diarrhea among the studied population, although this dataset does not allow an assessment of the benefit of seeking advice. One explanation is the possibility that travelers who seek pretravel medical advice at a travel clinic tend to return to the same clinic (ie, a GeoSentinel clinic) if they are sick, whereas those who did not seek pretravel health advice tend to go elsewhere for posttravel problems and are not captured in the GeoSentinel database. Travelers who seek pretravel advice may also be more likely to consult for posttravel symptoms, in general.
We observed a large difference in PI-IBS and chronic diarrhea diagnoses between North Americans and Europeans; whereas a Refers to acute diarrhea due to a bacterial pathogen other than Clostridium difficile, Campylobacter species, Vibrio cholerae, Salmonella species, and Shigella species, which each one have a distinct diagnostic code.
travelers from the United States and Canada had a higher PM for PI-IBS, European travelers had a higher PM for chronic diarrhea. This finding may represent a difference in the definition and use of these diagnoses among medical practitioners on the different continents. Dermatologic illnesses had an important impact on travelers, especially those visiting Guatemala, Belize, Costa Rica, and Panama. The increased PM for dermatologic illnesses might be explained by a higher proportion of travelers visiting these areas for eco-travel, spending time in the forest and/or jungle, and sleeping in remote areas. Myiasis in Belize seems especially common. Most of the cutaneous leishmaniasis cases were diagnosed in travelers who had visited Costa Rica and Belize. Although cutaneous leishmaniasis is an endemic disease in Central America, mucocutaneous [8] and visceral [9] leishmaniasis are rarely identified. Mucocutaneous leishmaniasis was confirmed in a 64-year-old German man who traveled to Costa Rica during February 2004. Travelers to Central America should be advised on measures to prevent insect bites and secondary infections of these lesions and management of cuts and small injuries that can predispose to cellulitis and prevention of dermatophytes.
Vaccine-preventable illnesses were observed among ill returned travelers from developed nations, where vaccines are widely available. These cases included a 68-year-old American man traveling to Guatemala during January 2007 and a 24-yearold American woman traveling to Costa Rica during June 2009, both of whom received a diagnosis of pertussis. Seven travelers from the United States, Canada, and Israel who returned from Mexico and Central America during January 2000-October 2007 received a diagnosis of acute hepatitis A infection; the youngest was 7 years of age, and the oldest was 57 years of age. In addition, a rubella case was identified in a 33-year-old female, Brazilian US resident traveling to Costa Rica in 2008. As was shown by Boggild et al [10] , these findings highlight the importance of using the pretravel consultation to catch-up on routine vaccinations that may have been missed and those indicated primarily for travel. [11] . Although our study was not designed to provide an assessment of current malaria risk and prophylactic effectiveness among travelers, the PM for malaria in Honduras (79.6 cases per 1000 persons) and Guatemala (34.4 cases per 1000 persons) was found to be significantly higher than in the other studied countries. Most of the identified malaria cases in the GeoSentinel database were caused by P. vivax rather than P. falciparum, and some cases might represent previously acquired relapsing disease [12] . We identified 4 malaria cases in Mexico, including 2 in US leisure travelers who visited Tulum (located in the state of Quintana Roo, bordering Guatemala) during January 2007 and were hospitalized after their return. The other 2 malaria cases, presumably acquired in Mexico, were in adult Canadians traveling during 2000; however, complete travel information and exposure details were not available. Malaria transmission in Mexico continues to decrease, and chemoprophylaxis against malaria is not routinely indicated for travelers visiting Mexico except some rarely visited regions, most notably, in Chiapas and Oaxaca. For Central America, detailed recommendations can be found on the Centers for Disease Control and Prevention Travelers' Health Web site (www.cdc. gov/travel). In general, only travelers to Costa Rica, Panama west of the canal, or El Salvador will require chemoprophylaxis.
Beginning in April 2009, the GeoSentinel Surveillance Network recorded an increased PM associated with all respiratory illnesses. During the 2009 H1N1 influenza outbreak, an increased awareness of the potential health risks of traveling to Mexico among returning travelers may have also led to the increased numbers of patients visiting travel medicine clinics for 2009 H1N1 influenza screening. Some differences among travelers to Mexico were observed after the onset of the 2009 H1N1 influenza pandemic. The proportion of ill leisure travelers returning from Mexico remained constant after March 2009, when the H1N1 influenza outbreak was identified. Because the proportion of travelers who obtained pretravel health advice decreased, we hypothesize either that those who consulted health care practitioners before travel were advised not to travel to this area or that most of the leisure travelers visiting Mexico during the H1N1 influenza outbreak chose not to visit a travel medicine clinic. The increase in hospitalizations may have been a result of travelers being more likely to consult for respiratory symptoms, because of the general concern about H1N1 influenza at the time.
This descriptive analysis from the GeoSentinel database has several limitations. First, the database represents ill travelers seeking medical care at GeoSentinel sites; thus, the data do not represent a comprehensive epidemiologic analysis of all travelers. Second, because no information related to healthy travelers was recorded and no denominator was available, we could not estimate rates or risk of travel-related illness. Third, because most GeoSentinel sites are travel or tropical medicine clinics located in Europe and North America, diseases with short incubation periods and/or self-limited symptoms that might manifest during travel may be underrepresented in the database. Fourth, GeoSentinel clinics tend to be referral clinics. As such, diseases with more severe, persistent, or complex and/or unusual clinical signs or symptoms might be overrepresented. Fifth, some GeoSentinel clinics might have different proportions of certain types of travelers; for example, American clinics are more likely to see more travelers visiting friends or relatives in Latin America, because of the higher proportion of Hispanic residents in the United States. Sixth, the GeoSentinel database is designed to collect epidemiologic information based on the diagnosis made by the practitioner seeing the ill traveler and depends on the best knowledge and resources available locally. Seventh, the GeoSentinel database collects predefined epidemiologic information and not additional detailed clinical information, such as the administration of prophylaxis, vaccines, or medication used by the traveler while in the destination country. Last, a proportion of exposure countries were missing or unascertainable as determined by the clinician; analysis based on exposure country may not be representative of travelers exposed in Mexico or Central America.
The information presented here provides a profile for practitioners seeing travelers returned from Mexico and Central America. The differences in proportionate morbidities seen in different regions of Central America can help guide pretravel interventions. In addition, this study describes the impact of the H1N1 influenza epidemic in Mexico and Central America on respiratory illness in returning travelers and illustrates how the GeoSentinel network can reflect such an outbreak.
